oral semaglutide novo Article » PBD FDA vs. HIMS: Why the

Bea S, Iyer GS, Kim DH, et al

If you're experiencing significant bloating on GLP-1 therapy, discussing your genetic and metabolic profile with your PlexusDx provider can support a more targeted approach

A team from Heliopolis University in Cairo, led by microbiologist Tohada AL-Noshokaty, wants to "usher in a new age of GLP-1 regulation by tapping into nature's resources." "Patient compliance and quality of life could be greatly enhanced by using natural GLP-1 modulators, which may be easier on the body," the authors suggest in a review for Toxicology Reports published in June

If it does get the green light, it will have been a long time coming